The DABBEC Phenotyping System: Towards a mechanistic understanding of CP/CPPS

Nature Reviews Urology

Volumn 8, Issue 2, 2011, Pages 107-113

  Allsop, Stephen A ^a   Erstad, Derek J ^a   Brook, Karolina ^a   Bhai, Salman F ^a   Cohen, Jeffrey M ^a   Dimitrakoff, Jordan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; CORTICOSTERONE; CORTODOXONE; CYTOCHROME P450; CYTOCHROME P450 21A2; DEOXYCORTICOSTERONE; HYDROXYPROGESTERONE; PLACEBO; PROGESTERONE; PROGLUMIDE; PROTEOME; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ALGORITHM; CHRONIC PROSTATITIS; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENOME; GENOMICS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NIH CHRONIC PROSTATITIS SYMPTOM INDEX; PATHOGENESIS; PELVIS PAIN SYNDROME; PHENOTYPE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; REVIEW; SYMPTOM; TREATMENT FAILURE; TREATMENT RESPONSE;

ANIMALS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; MALE; PELVIC PAIN; PHENOTYPE; PROSTATITIS;

EID: 79951511557     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.227     Document Type: Review

References (44)

1. Krieger, J. N., Nyberg, L. Jr & Nickel, J. C. NIH consensus definition and classification of prostatitis. JAMA 282, 236-237 (1999). (Pubitemid 29343164)
2. Collins, M. M., Stafford, R. S., O'Leary, M. P. & Barry, M. J. How common is prostatitis? A national survey of physician visits. J. Urol. 159, 1224-1228 (1998). (Pubitemid 28172801)
3. Calhoun, E. A. et al. The economic impact of chronic prostatitis. Arch. Intern. Med. 164, 1231-1236 (2004). (Pubitemid 39030361)
4. McNaughton Collins, M. et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J. Gen. Intern. Med. 16, 656-662 (2001). (Pubitemid 32964845)
5. Propert, K. J. et al. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology 59, 870-876 (2002). (Pubitemid 34522179)
6. Pontari, M. A. & Ruggieri, M. R. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. 172, 839-845 (2004). (Pubitemid 39096404)
7. Rodriguez, M. A. et al. Evidence for overlap between urological and nonurological unexplained clinical conditions. J. Urol. 182, 2123-2131 (2009).
8. Litwin, M. S. et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J. Urol. 162, 369-375 (1999). (Pubitemid 29434343)
9. Alexander, R. B. et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann. Intern. Med. 141, 581-589 (2004). (Pubitemid 39390535)
10. Nickel, J. C. et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N. Engl. J. Med. 359, 2663-2673 (2008).
11. Shoskes, D. A., Nickel, J. C., Dolinga, R. & Prots, D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 73, 538-542 (2009).
12. Nickel, J. C. & Shoskes, D. Phenotypic approach to the management of chronic prostatitis/chronic pelvic pain syndrome. Curr. Urol. Rep. 10, 307-312 (2009).
13. Shoskes, D. A., Nickel, J. C. & Kattan, M. W. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 75, 1249-1253 (2010).
14. th edn (eds. Wein, A. J. et al.) 312-314 (Saunders, Philadelphia, 2007).
15. Nickel, J. C. Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome. Urology 60, 20-22; discussion 22-23 (2002).
16. Latremoliere, A. & Woolf, C. J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895-926 (2009).
17. Scholz, J. & Woolf, C. J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10, 1361-1368 (2007). (Pubitemid 350014681)
18. Woolf, C. J. & Ma, Q. Nociceptors-noxious stimulus detectors. Neuron 55, 353-364 (2007). (Pubitemid 47126273)
19. Costigan, M., Scholz, J. & Woolf, C. J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 32, 1-32 (2009).
20. Patapoutian, A., Tate, S. & Woolf, C. J. Transient receptor potential channels: targeting pain at the source. Nat. Rev. Drug Discov. 8, 55-68 (2009).
21. Nickel, J. C. et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 103, 910-918 (2009).
22. Anderson, R. U., Orenberg, E. K., Morey, A., Chavez, N. & Chan, C. A. Stress induced hypothalamus-pituitary-adrenal axis responses and disturbances in psychological profiles in men with chronic prostatitis/chronic pelvic pain syndrome. J. Urol. 182, 2319-2324 (2009).
23. Lutgendorf, S. K. et al. Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J. Urol. 167, 1338-1343 (2002). (Pubitemid 34132085)
24. Mcewen, B. S. & Kalia, M. The role of corticosteroids and stress in chronic pain conditions. Metabolism 59 (Suppl. 1), S9-S15 (2010).
25. Ganzel, B. L., Morris, P. A. & Wethington, E. Allostasis and the human brain: integrating models of stress from the social and life sciences. Psychol. Rev. 117, 134-174 (2010).
26. Dimitrakov, J. et al. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 71, 261-266 (2008). (Pubitemid 351282353)
27. Nimkarn, S. & New, M. I. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a paradigm for prenatal diagnosis and treatment. Ann. NY Acad. Sci. 1192, 5-11 (2010).
28. Cohen, H., Neumann, L., Glazer, Y., Ebstein, R. P. & Buskila, D. The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158)met and fibromyalgia. Clin. Exp. Rheumatol. 27 (5 Suppl. 56), S51-S56 (2009).
29. Tegeder, I. et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat. Med. 12, 1269-1277 (2006). (Pubitemid 44706929)
30. Ross, S. E. et al. Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron 65, 886-898 (2010).
31. Patte-Mensah, C. et al. Neurogenic pain and steroid synthesis in the spinal cord. J. Mol. Neurosci. 28, 17-31 (2006).
32. Schaeffer, V., Meyer, L., Patte-Mensah, C. & Mensah-Nyagan, A. G. Progress in dorsal root ganglion neurosteroidogenic activity: basic evidence and pathophysiological correlation. Prog. Neurobiol. 92, 33-41 (2010).
33. Savoye-Collet, C., Koning, E. & Dacher, J. N. Radiologic evaluation of pelvic floor disorders. Gastroenterol. Clin. North Am. 37, 553-567 (2008).
34. Siddall, P. J. et al. Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report. Anesth. Analg. 102, 1164-1168 (2006).
35. Kuchinad, A. et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J. Neurosci. 27, 4004-4007 (2007). (Pubitemid 46597143)
36. Schmidt-Wilcke, T. et al. Striatal grey matter increase in patients suffering from fibromyalgia-a voxel-based morphometry study. Pain 132 (Suppl. 1), S109-S116 (2007). (Pubitemid 350030865)
37. Dunckley, P. et al. Cortical processing of visceral and somatic stimulation: differentiating pain intensity from unpleasantness. Neuroscience 133, 533-542 (2005). (Pubitemid 40726219)
38. Schaeffer, A. J., Parks, E. L. & Apkarian, A. V. Brain Activity for spontaneous fluctuations of pain in urologic pelvic pain syndrome [abstract]. J. Urol. 181 (Suppl. 4), 121 (2009).
39. Bjerklund Johansen, T. E. & Weidner, W. Understanding chronic pelvic pain syndrome. Curr. Opin. Urol. 12, 63-67 (2002). (Pubitemid 34033070)
40. Katsnelson, A. Researchers probe the real effect of placebos. Nat. Med. 11, 105 (2005). (Pubitemid 40321331)
41. Finniss, D. G., Kaptchuk, T. J., Miller, F. & Benedetti, F. Biological, clinical, and ethical advances of placebo effects. Lancet 375, 686-695 (2010).
42. Benedetti, F., Amanzio, M. & Maggi, G. Potentiation of placebo analgesia by proglumide. Lancet 346, 1231 (1995).
43. D'Agostino, R. B. Sr. The delayed-start study design. N. Engl. J. Med. 361, 1304-1306 (2009).
44. Colloca, L., Lopiano, L., Lanotte, M. & Benedetti, F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 3, 679-684 (2004). (Pubitemid 39370638)